# 119-hr-6852: Advanced Wound Care and Regenerative Medicine Access and Reform Act

119-hr-6852, Advanced Wound Care and Regenerative Medicine Access and Reform Act, is a 119th Congress bill sponsored by Rep. Evans, Gabe [R-CO-8] (R-CO); status introduced; PRIA reads it as touching household money (as of 2026-08-29).

- Canonical: https://policyrisk.com/legislation/119-hr-6852
- As of: 2026-08-29
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-6852
- Congress: 119
- Title: Advanced Wound Care and Regenerative Medicine Access and Reform Act
- Status: introduced
- Introduced: 2025-12-18
- Sponsor: Rep. Evans, Gabe [R-CO-8] (R-CO)
- Cosponsors: 2
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-08-29

## Summary

**Creates a dedicated Medicare payment framework for skin substitute products.** H.R. 6852 would add skin substitutes to Medicare coverage and set a new, data-driven payment system that applies across care settings.

## Cosponsors (2)

- Rep. Gooden, Lance [R-TX-5] (R-TX), 2026-02-03T00:00:00.000Z
- Rep. McCormick, Richard [R-GA-7] (R-GA), 2026-08-27T00:00:00.000Z

## Provisions PRIA read

- Medicare adds skin substitute coverage: benefit, medium. If enacted, Medicare would add a new covered category for skin substitute products starting January 1, 2026. Covered products would be cellular, tissue, biological, or synthetic materials meant to remain in the wound and marketed under applicable FDA or Public Health Service authorities. The rule w…
- FDA review to speed tissue approvals: benefit, medium. If enacted, the HHS Secretary would direct the FDA to review approval rules for certain human tissue allografts and autografts within 18 months. The review would look at evidence needs, timelines, and a possible tiered risk approach. The agency would consult manufacturers, clinicians, patients, pay…
- New Medicare payments for wound products: mixed, high. If enacted, Medicare would adopt a single payment system for skin substitute wound products on January 1, 2026. CMS would create one billing code for all covered skin substitute products by that date. The 2026 payment would be a volume‑weighted average using the April 2023 ASP Pricing File and 2023…
- Stricter reviews for high‑payment providers: mixed, medium. If enacted, CMS would identify the top 3 percent of providers by skin substitute payments starting by March 1, 2026 and every two years through March 1, 2035. CMS would publish that list and send it to the HHS Inspector General. Claims from those outlier providers could face prepayment review begin…

## Related bills

- 119-hr-3151: SHIPS for America Act of 2025
- 119-hr-7613: ALERT Act
- 119-hr-4393: DIGNIDAD (Dignity) Act of 2025
- 119-hr-9298: Stopping Harmful and Outrageous Torts Act
- 119-hr-1262: Mikaela Naylon Give Kids a Chance Act
- 119-hr-2853: Combating Organized Retail Crime Act of 2025

## Sources
- [119-hr-6852 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/6852)

## Related
- [119-hr-3151: SHIPS for America Act of 2025](https://policyrisk.com/legislation/119-hr-3151)
- [119-hr-7613: ALERT Act](https://policyrisk.com/legislation/119-hr-7613)
- [119-hr-4393: DIGNIDAD (Dignity) Act of 2025](https://policyrisk.com/legislation/119-hr-4393)
- [119-hr-9298: Stopping Harmful and Outrageous Torts Act](https://policyrisk.com/legislation/119-hr-9298)
- [119-hr-1262: Mikaela Naylon Give Kids a Chance Act](https://policyrisk.com/legislation/119-hr-1262)
- [119-hr-2853: Combating Organized Retail Crime Act of 2025](https://policyrisk.com/legislation/119-hr-2853)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-6852 (as of 2026-08-29).